Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5850_Библиотеки_им_академика_М_И_Перельмана
.pdf
156
https://t.me/medicina_free
M. Chatterjee et al.
5. Weiderpass E. Lifestyle and cancer risk. J Prev Med
Public Health. 2010;43(6):459–71. https://doi.org/10.3961/
jpmph.2010.43.6.459.
6. Parkin DM.The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118(12):3030–44. https://
doi.org/10.1002/ijc.21731.
7. Anand P, Kunnumakkara AB, Sundaram C, Harikumar KB,
Tharakan ST, Lai OS, Sung B, Aggarwal BB. Cancer is a
preventable disease that requires major lifestyle changes.
Pharm Res. 2008;25(9):2097–116. https://doi.org/10.1007/
s11095- 008- 9661- 9.
8. Sloan FA, Gelband H, Institute of Medicine (US) Committee on
Cancer Control in Low- and Middle-Income Countries. Cancer
control opportunities in low- and middle-income countries.
Washington: National Academies Press; 2007. https://www.ncbi.
nlm.nih.gov/books/NBK54030/.
9. Song M, Garrett WS, Chan AT. Nutrients, foods, and colorectal cancer prevention. Gastroenterology. 2015;148(6):1244–60.
https://doi.org/10.1053/j.gastro.2014.12.035.
10. Park OJ, Surh YJ. Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and
laboratory studies. Toxicol Lett. 2004;150(1):43–56. https://doi.
org/10.1016/j.toxlet.2003.06.001.
11. Hanahan D, Weinberg RA.Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74. https://doi.org/10.1016/j.
cell.2011.02.013.
12. Cairns RA, Harris IS, Mak TW.Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11:85–95. https://doi.org/10.1038/
nrc2981.
13. Henley SA, Dick FA.The retinoblastoma family of proteins and
their regulatory functions in the mammalian cell division cycle.
Cell Div. 2012;7:10. https://doi.org/10.1186/1747- 1028- 7- 10.
14. Bieging KT, Mello SS, Attardi LD. Unravelling mechanisms of p53-mediated tumor suppression. Nat Rev Cancer.
2014;14(5):359–70. https://doi.org/10.1038/nrc3711.
15. Giacinti C, Giordano A.RB and cell cycle progression. Oncogene.
2006;25(38):5220–7. https://doi.org/10.1038/sj.onc.1209615.
16. Umen JG, Goodenough UW. Control of cell division by a retinoblastoma protein homolog in Chlamydomonas. Genes Dev.
2001;15(13):1652–61. https://doi.org/10.1101/gad.892101.
17. Nakamura Y, Ozaki T, Niizuma H, Ohira M, Kamijo T,
Nakagawara A.Functional characterization of a new p53 mutant
generated by homozygous deletion in a neuroblastoma cell line.
Biochem Biophys Res Commun. 2007;354(4):892–8. https://doi.
org/10.1016/j.bbrc.2007.01.057.
18. Ozaki T, Nakagawara A. Role of p53 in cell death and human
cancers. Cancer. 2011;3(1):994–1013. https://doi.org/10.3390/
cancers3010994.
19. Rivlin N, Brosh R, Oren M, Rotter V.Mutations in the p53 tumor
suppressor gene: important milestones at the various steps of
tumorigenesis. Genes Cancer. 2011;2(4):466–74. https://doi.
org/10.1177/1947601911408889.
20. Bugyik E, Renyi-Vamos F, Szabo V, Dezso K, Ecker N, Rokusz
A, Nagy P, Dome B, Paku S.Mechanisms of vascularization in
murine models of primary and metastatic tumor growth. Chin J
Cancer. 2016;35:19. https://doi.org/10.1186/s40880- 016- 0083- 5.
21. Nishida N, Yano H, Nishida T, Kamura T, Kojiro M.Angiogenesis
in cancer. Vasc Health Risk Manag. 2006;2(3):213–9. https://doi.
org/10.2147/vhrm.2006.2.3.213.
22. Veikkola T, Alitalo K. VEGFs, receptors and angiogenesis.
Semin Cancer Biol. 1999;9(3):211–20. https://doi.org/10.1006/
scbi.1998.0091.
23. Bello L, Francolini M, Marthyn P, Zhang J, Carroll RS,
Nikas DC, Strasser JF, Villani R, Cheresh DA, Black
PM. Alpha(v)beta3 and alpha(v)beta5 integrin expression in
glioma periphery. Neurosurgery. 2001;49(2):380–9. https://doi.
org/10.1097/00006123- 200108000- 00022.
24. Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer.
2010;10(1):9–22. https://doi.org/10.1038/nrc2748.
25. Hamidi H, Ivaska J.Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer. 2018;18:533–48. https://
doi.org/10.1038/s41568- 018- 0038- z.
26. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter
P. Molecular biology of the cell. 4th ed. New York: Garland
Science; 2002. https://doi.org/10.1002/bmb.2003.494031049999.
27. Donaldson MS. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J. 2004;3:19. https://doi.
org/10.1186/1475- 2891- 3- 19.
28. Da Ponte KF, Berro DH, Collet S, Constans JM, Emery E,
Valable S, Guillamo JS. In vivo relationship between hypoxia
and angiogenesis in human glioblastoma: a multimodal imaging study. J Nucl Med. 2017;58:1574–9. https://doi.org/10.2967/
jnumed.116.188557.
29. Doglioni G, Parik S, Fendt SM.Interactions in the (pre)metastatic
niche support metastasis formation. Front Oncol. 2019;9:219.
https://doi.org/10.3389/fonc.2019.00219.
30. Cacace A, Sboarina M, Vazeille T, Sonveaux P. Glutamine activates STAT3 to control cancer cell proliferation independently of
glutamine metabolism. Oncogene. 2017;36:2074–84. https://doi.
org/10.1038/onc.2016.364.
31. Pan M, Reid MA, Lowman XH, Kulkarni RP, Tran TQ, Liu X,
Yang Y, Hernandez-Davies JE, Rosales KK, Li H, etal. Regional
glutamine deciency in tumors promotes dedifferentiation through
inhibition of histone demethylation. Nat Cell Biol. 2016;18:1090–
101. https://doi.org/10.1038/ncb3410.
32. McRae MP.The benets of dietary ber intake on reducing the risk
of cancer: an umbrella review of meta-analyses. J Chiropr Med.
2018;17(2):90–6. https://doi.org/10.1016/j.jcm.2017.12.001.
33. Chen S, Chen Y, Ma S, Zheng R, Zhao P, Zhang L, Liu Y, Yu Q,
Deng Q, Zhang K.Dietary bre intake and risk of breast cancer:
a systematic review and meta-analysis of epidemiological studies. Oncotarget. 2016;7(49):80980–9. https://doi.org/10.18632/
oncotarget.13140.
34. Dong JY, He K, Wang P, Qin LQ. Dietary ber intake and risk
of breast cancer: a meta-analysis of prospective cohort studies. Am J Clin Nutr. 2011;94(3):900–5. https://doi.org/10.3945/
ajcn.111.015578.
35. Kim Y, Je Y.Dietary bre intake and mortality from cardiovascular disease and all cancers: a meta-analysis of prospective cohort
studies. Arch Cardiovasc Dis. 2016;109(1):39–54. https://doi.
org/10.1016/j.acvd.2015.09.005.
36. Augustin LS, Gallus S, Negri E, La Vecchia C.Glycemic index,
glycemic load and risk of gastric cancer. Ann Oncol. 2004;15:581–
4. https://doi.org/10.1093/annonc/mdh130.
37. Augustin LS, Gallus S, Franceschi S, Negri E, Jenkins DJ,
Kendall CW, Dal Maso L, Talamini R, La Vecchia C.Glycemic
index and load and risk of upper aero-digestive tract neoplasms
(Italy). Cancer Causes Control. 2003;14:657–62. https://doi.org/1
0.1023/a:1025676907942.
38. Augustin LS, Polesel J, Bosetti C, Kendall CW, La Vecchia C,
Parpinel M, Conti E, Montella M, Franceschi S, Jenkins DJ, Dal
Maso L.Dietary glycemic index, glycemic load and ovarian cancer risk: a case-control study in Italy. Ann Oncol. 2003;14:78–84.
https://doi.org/10.1093/annonc/dkg022.
39. Augustin LS, Gallus S, Bosetti C, Levi F, Negri E, Franceschi S,
Dal Maso L, Jenkins DJ, Kendall CW, La Vecchia C.Glycemic
index and glycemic load in endometrial cancer. Int J Cancer.
2003;105:404–7. https://doi.org/10.1002/ijc.11089.
40. Franceschi S, Dal Maso L, Augustin L, Negri E, Parpinel M,
Boyle P, Jenkins DJ, La Vecchia C. Dietary glycemic load and
Role ofLifestyle Modication andDiet inthePrevention ofCancer
https://t.me/medicina_free
157
colorectal cancer risk. Ann Oncol. 2001;12:173–8. https://doi.org
/10.1023/a:1008304128577.
41. Slattery ML, Boucher KM, Caan BJ, Potter JD, Ma KN.Eating
patterns and risk of colon cancer. Am J Epidemiol. 1998;148:4–
16. https://doi.org/10.1093/aje/148.1.4- a.
42. Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M,
Tracy RP, Dobs A, Savage PJ.Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst.
1999;91:1147–54. https://doi.org/10.1093/jnci/91.13.1147.
43. Calle EE, Murphy TK, Rodriguez C, Thun MJ, Heath CW Jr.
Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults. Cancer Causes Control.
1998;9:403–10. https://doi.org/10.1023/a:1008819701485.
44. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ.Diabetes
mellitus as a predictor of cancer mortality in a large cohort
of US adults. Am J Epidemiol. 2004;159:1160–7. https://doi.
org/10.1093/aje/kwh161.
45. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K.Colorectal
cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomark Prev. 2002;11:385–91. https://
pubmed.ncbi.nlm.nih.gov/11927499/.
46. La Vecchia C, Negri E, Decarli A, Franceschi S.Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomark Prev.
1997;6:1007–10. https://pubmed.ncbi.nlm.nih.gov/9419395/.
47. Sandhu MS, Luben R, Khaw KT. Self-reported non-insulin
dependent diabetes, family history, and risk of prevalent colorectal cancer: population based, cross sectional study. J Epidemiol
Community Health. 2001;55:804–5. https://doi.org/10.1136/
jech.55.11.804.
48. Anderson KE, Anderson E, Mink PJ, Hong CP, Kushi LH, Sellers
TA, Lazovich D, Folsom AR.Diabetes and endometrial cancer in
the Iowa women’s health study. Cancer Epidemiol Biomark Prev.
2001;10:611–6. https://pubmed.ncbi.nlm.nih.gov/11401910/.
49. Cho E, Spiegelman D, Hunter DJ, Chen WY, Colditz GA, Willett
WC. Premenopausal dietary carbohydrate, glycemic index, glycemic load, and ber in relation to risk of breast cancer. Cancer
Epidemiol Biomark Prev. 2003;12(11):1153–8. https://pubmed.
ncbi.nlm.nih.gov/14652274/.
50. Cho E, Spiegelman D, Hunter DJ, Chen WY, Stampfer MJ,
Colditz GA, Willett WC. Premenopausal fat intake and risk of
breast cancer. J Natl Cancer Inst. 2003;95(14):1079–85. https://
doi.org/10.1093/jnci/95.14.1079.
51. Wen W, Shu XO, Li H, Yang G, Ji BT, Cai H, Gao YT, Zheng
W. Dietary carbohydrates, ber, and breast cancer risk in
Chinese women. Am J Clin Nutr. 2009;89(1):283–9. https://doi.
org/10.3945/ajcn.2008.26356.
52. Aune D, Chan DS, Lau R, Vieira R, Greenwood DC, Kampman
E, Norat T. Carbohydrates, glycemic index, glycemic load, and
colorectal cancer risk: a systematic review and meta-analysis
of cohort studies. Cancer Causes Control. 2012;23(4):521–35.
https://doi.org/10.1007/s10552- 012- 9918- 9.
53. Hanson S, Thorpe G, Winstanley L. Omega-3, omega-6 and
total dietary polyunsaturated fat on cancer incidence: systematic review and meta-analysis of randomised trials. Br J Cancer.
2020;122:1260–70. https://doi.org/10.1038/s41416- 020- 0761- 6.
54. Bernard-Gallon DJ, Vissac-Sabatier C, Antoine-Vincent D, Rio
PG, Maurizis JC, Fustier P, Bignon YJ. Differential effects of
n-3 and n-6 polyunsaturated fatty acids on BRCA1 and BRCA2
gene expression in breast cell lines. Br J Nutr. 2002;87(4):281–9.
https://doi.org/10.1079/bjnbjn2002522.
55. Freitas RDS, Campos MM. Protective effects of omega-3 fatty
acids in cancer-related complications. Nutrients. 2019;11(5):945.
https://doi.org/10.3390/nu11050945.
56. Laviano A, Rianda S, Molno A, Rossi Fanelli F.Omega-3 fatty
acids in cancer. Curr Opin Clin Nutr Metab Care. 2013;16(2):156–
61. https://doi.org/10.1097/mco.0b013e32835d2d99.
57. Murphy RA, Mourtzakis M, Mazurak VC. n-3 polyunsaturated
fatty acids: the potential role for supplementation in cancer. Curr
Opin Clin Nutr Metab Care. 2012;15(3):246–51. https://doi.
org/10.1097/mco.0b013e328351c32f.
58. Pardini RS. Nutritional intervention with omega-3 fatty acids
enhances tumor response to anti-neoplastic agents. Chem
Biol Interact. 2006;162(2):89–105. https://doi.org/10.1016/j.
cbi.2006.05.012.
59. Wirfält E, Mattisson I, Gullberg B, Johansson U, Olsson H,
Berglund G.Postmenopausal breast cancer is associated with high
intakes of omega6 fatty acids (Sweden). Cancer Causes Control.
2002;13(10):883–93. https://doi.org/10.1023/a:1021922917489.
60. Farvid MS, Stern MC, Norat T, Sasazuki S, Vineis P, Weijenberg
MP, Wolk A, Wu K, Stewart BW, Cho E. Consumption of red
and processed meat and breast cancer incidence: a systematic
review and meta-analysis of prospective studies. Int J Cancer.
2018;143(11):2787–99. https://doi.org/10.1002/ijc.31848.
61. Farvid MS, Sidahmed E, Spence ND, ManteAngua K, Rosner
BA, Barnett JB.Consumption of red meat and processed meat and
cancer incidence: a systematic review and meta-analysis of prospective studies. Eur J Epidemiol. 2021;36(9):937–51. https://doi.
org/10.1007/s10654- 021- 00741- 9.
62. Chiavarini M, Bertarelli G, Minelli L, Fabiani R.Dietary intake
of meat cooking-related mutagens (HCAs) and risk of colorectal adenoma and cancer: a systematic review and meta-analysis.
Nutrients. 2017;9(5):514. https://doi.org/10.3390/nu9050514.
63. Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, Kampman
E, Norat T. Red and processed meat and colorectal cancer
incidence: meta-analysis of prospective studies. PLoS One.
2011;6(6):e20456. https://doi.org/10.1371/journal.pone.0020456.
64. Keszei AP, Schouten LJ, Goldbohm RA, van den Brandt PA.Red
and processed meat consumption and the risk of esophageal and
gastric cancer subtypes in The Netherlands Cohort Study. Ann
Oncol. 2012;23(9):2319–26. https://doi.org/10.1093/annonc/
mdr615.
65. Kim SR, Kim K, Lee SA, Kwon SO, Lee JK, Keum N, Park
SM.Effect of red, processed, and white meat consumption on the
risk of gastric cancer: an overall and dose-response meta-analysis.
Nutrients. 2019;11(4):826. https://doi.org/10.3390/nu11040826.
66. Zhao Z, Yin Z, Zhao Q.Red and processed meat consumption
and gastric cancer risk: a systematic review and meta-analysis.
Oncotarget. 2017;8(18):30563–75. https://doi.org/10.18632/
oncotarget.15699.
67. Cross AJ, Freedman ND, Ren J, Ward MH, Hollenbeck AR,
Schatzkin A, Sinha R, Abnet CC.Meat consumption and risk of
esophageal and gastric cancer in a large prospective study. Am
J Gastroenterol. 2011;106(3):432–42. https://doi.org/10.1038/
ajg.2010.415.
68. Qu X, Ben Q, Jiang Y. Consumption of red and processed meat
and risk for esophageal squamous cell carcinoma based on a
meta-analysis. Ann Epidemiol. 2013;23(12):762–70. https://doi.
org/10.1016/j.annepidem.2013.09.003.
69. Salehi M, Moradi-Lakeh M, Salehi MH, Nojomi M, Kolahdooz
F. Meat, sh, and esophageal cancer risk: a systematic review
and dose-response meta-analysis. Nutr Rev. 2013;71(5):257–67.
https://doi.org/10.1111/nure.12028.
70. Zhu HC, Yang X, Xu LP, Zhao LJ, Tao GZ, Zhang C, Qin Q,
Cai J, Ma JX, Mao WD, Zhang XZ, Cheng HY, Sun XC. Meat
consumption is associated with esophageal cancer risk in a meatand cancer-histological-type dependent manner. Dig Dis Sci.
2014;59(3):664–73. https://doi.org/10.1007/s10620- 013- 2928- y.
71. Cunnane SC, Ganguli S, Menard C, Liede AC, Hamadeh MJ, Chen
ZY, Wolever TM, Jenkins DJ.High alpha-linolenic acid axseed
(Linumusitatissimum): some nutritional properties in humans. Br
J Nutr. 1993;69(2):443–53. https://doi.org/10.1079/bjn19930046.
158
https://t.me/medicina_free
M. Chatterjee et al.
72. Flower G, Fritz H, Balneaves LG, Verma S, Skidmore B, Fernandes
R, Kennedy D, Cooley K, Wong R, Sagar S, Fergusson D, Seely
D.Flax and breast cancer: a systematic review. Integr Cancer Ther.
2014;13(3):181–92. https://doi.org/10.1177/1534735413502076.
73. Thompson LU, Rickard SE, Orcheson LJ, Seidl MM.Flaxseed and
its lignan and oil components reduce mammary tumor growth at a
late stage of carcinogenesis. Carcinogenesis. 1996;17(6):1373–6.
https://doi.org/10.1093/carcin/17.6.1373.
74. Li D, Yee JA, Thompson LU, Yan L. Dietary supplementation
with secoisolariciresinoldiglycoside (SDG) reduces experimental
metastasis of melanoma cells in mice. Cancer Lett. 1999;142(1):91–
6. https://doi.org/10.1016/s0304- 3835(99)00158- 5.
75. Yan L, Yee JA, Li D, McGuire MH, Thompson LU. Dietary
axseed supplementation and experimental metastasis of melanoma cells in mice. Cancer Lett. 1998;124(2):181–6. https://doi.
org/10.1016/s0304- 3835(97)00470- 9.
76. Lin X, Gingrich JR, Bao W, Li J, Haroon ZA, Demark-Wahnefried
W. Effect of axseed supplementation on prostatic carcinoma
in transgenic mice. Urology. 2002;60(5):919–24. https://doi.
org/10.1016/s0090- 4295(02)01863- 0.
77. Fleischauer AT, Poole C, Arab L.Garlic consumption and cancer prevention: meta-analyses of colorectal and stomach cancers.
Am J Clin Nutr. 2000;72(4):1047–52. https://doi.org/10.1093/
ajcn/72.4.1047.
78. Fowke JH, Chung FL, Jin F, Qi D, Cai Q, Conaway C, Cheng JR,
Shu XO, Gao YT, Zheng W. Urinary isothiocyanate levels, brassica, and human breast cancer. Cancer Res. 2003;63(14):3980–6.
https://pubmed.ncbi.nlm.nih.gov/12873994/.
79. London SJ, Yuan JM, Chung FL, Gao YT, Coetzee GA, Ross RK,
Yu MC. Isothiocyanates, glutathione S-transferase M1 and T1
polymorphisms, and lung-cancer risk: a prospective study of men
in Shanghai, China. Lancet. 2000;356(9231):724–9. https://doi.
org/10.1016/s0140- 6736(00)02631- 3.
80. Fowke JH, Gao YT, Chow WH, Cai Q, Shu XO, Li HL, Ji BT,
Rothman N, Yang G, Chung FL, Zheng W.Urinary isothiocyanate
levels and lung cancer risk among non-smoking women: a prospective investigation. Lung Cancer. 2011;73(1):18–24. https://
doi.org/10.1016/j.lungcan.2010.10.024.
81. Diallo A, Deschasaux M, Galan P, Hercberg S, Zelek L, LatinoMartel P, Touvier M. Associations between fruit, vegetable and
legume intakes and prostate cancer risk: results from the prospective SupplémentationenVitamines et MinérauxAntioxydants (SU.
VI.MAX) cohort. Br J Nutr. 2016;115(9):1579–85. https://doi.
org/10.1017/s0007114516000520.
82. Barnard RJ.Prevention of cancer through lifestyle changes. Evid
Based Complement Alternat Med. 2004;1(3):233–9.
83. Martínez ME, Jacobs ET, Ashbeck EL, Sinha R, Lance P,
Alberts DS, Thompson PA. Meat intake, preparation methods,
mutagens and colorectal adenoma recurrence. Carcinogenesis.
2007;28(9):2019–27. https://doi.org/10.1093/carcin/bgm179.
84. Peters U, Sinha R, Chatterjee N, Subar AF, Ziegler RG, Kulldorff
M, Bresalier R, Weissfeld JL, Flood A, Schatzkin A, Hayes RB,
Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Project Team. Dietary bre and colorectal adenoma in a colorectal
cancer early detection programme. Lancet. 2003;361(9368):1491–
5. https://doi.org/10.1016/S0140- 6736(03)13173- X.
85. Giovannucci E. Diet, body weight, and colorectal cancer: a
summary of the epidemiologic evidence. J Women’s Health.
2003;12:173–82. https://doi.org/10.1089/154099903321576574.
86. Komninou D, Ayonote A, Richie JP Jr, Rigas B. Insulin
resistance and its contribution to colon carcinogenesis. Exp Biol Med. 2003;228:396–405. https://doi.
org/10.1177/153537020322800410.
87. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst.
2000;92(18):1472–89. https://doi.org/10.1093/jnci/92.18.1472.
88. Slattery ML, Curtin K, Ma K, Edwards S, Schaffer D, Anderson
K, Samowitz W. Diet, activity, and lifestyle associations with
p53 mutations in colon tumors. Cancer Epidemiol Biomark Prev.
2002;11(6):541–8.
89. Feregrino-Pérez AA, Berumen LC, García-Alcocer G, GuevaraGonzalez RG, Ramos-Gomez M, Reynoso-Camacho R, AcostaGallegos JA, Loarca-Piña G.Composition and chemopreventive
effect of polysaccharides from common beans (Phaseolus vul-
garis L.) on azoxymethane-induced colon cancer. J Agric Food
Chem. 2008;56:8737–44. https://doi.org/10.1021/jf8007162.
90. Kaczmarczyk MM, Miller MJ, Freund GG. The health benets
of dietary ber: beyond the usual suspects of type 2 diabetes mellitus, cardiovascular disease and colon cancer. Metab Clin Exp.
2012;61:1058–66. https://doi.org/10.1016/j.metabol.2012.01.017.
91. Reddy BS, Hirose Y, Cohen LA, Simi B, Cooma I, Rao
CV. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer
prevention. Cancer Res. 2000;60:4792–7.
92. Surh YJ. Cancer chemoprevention with dietary phytochemicals.
Nat Rev Cancer. 2003;3:768–80. https://doi.org/10.1038/nrc1189.
93. Bingham SA, Day NE, Luben R, Ferrari P, Slimani N, Norat T,
Clavel-Chapelon F, Kesse E, Nieters A, Boeing H, Tjønneland
A, Overvad K, Martinez C, Dorronsoro M, Gonzalez CA, Key
TJ, Trichopoulou A, Naska A, Vineis P, Tumino R, Krogh V,
Bueno-de-Mesquita HB, Peeters PH, Berglund G, Hallmans
G, Lund E, Skeie G, Kaaks R, Riboli E, European Prospective
Investigation into Cancer and Nutrition. Dietary bre in food and
protection against colorectal cancer in the European Prospective
Investigation into Cancer and Nutrition (EPIC): an observational
study. Lancet. 2003;361:1496–501. https://doi.org/10.1016/
s0140- 6736(03)13174- 1.
94. Giovannucci E. Epidemiologic studies of folate and colorectal
neoplasia: a review. J Nutr. 2002;132(8 Suppl):2350S–5S. https://
doi.org/10.1093/jn/132.8.2350S.
95. Majumdar AP, Kodali U, Jaszewski R.Chemopreventive role of
folic acid in colorectal cancer. Front Biosci. 2004;9:2725–32.
https://doi.org/10.2741/1431.
96. Larsson SC, Orsini N, Wolk A.Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies. JAMA.
2010;303(11):1077–83. https://doi.org/10.1001/jama.2010.263.
97. Wozniak K, Arabski M, Malecka-Panas E, Drzewoski J, Blasiak
J.DNA damage in human colonic mucosa cells induced by bleomycin and the protective action of vitamin E.Cell Mol Biol Lett.
2003;9:31–45.
98. Błasiak J, Arabski M, Pertyński T, Małecka-Panas E, Woźniak K,
Drzewoski J.DNA damage in human colonic mucosa cells evoked
by nickel and protective action of quercetin- involvement of free
radicals? Cell Biol Toxicol. 2002;18(4):279–88. https://doi.org/10
.1023/a:1016059112829.
99. Ishikawa S, Tamaki S, Ohata M, Arihara K, Itoh M.Heme induces
DNA damage and hyperproliferation of colonic epithelial cells
via hydrogen peroxide produced by heme oxygenase: a possible
mechanism of heme-induced colon cancer. Mol Nutr Food Res.
2010;54:1182–91. https://doi.org/10.1002/mnfr.200900348.
100. Knobel Y, Weise A, Glei M, Sendt W, Claussen U, PoolZobel
BL.Ferric iron is genotoxic in non-transformed and pre- neoplastic
human colon cells. Food Chem Toxicol. 2007;45:804–11. https://
doi.org/10.1016/j.fct.2006.10.028.
101. O’Callaghan NJ, Toden S, Bird AR, Topping DL, Fenech M,
Conlon MA. Colonocyte telomere shortening is greater with
dietary red meat than white meat and is attenuated by resistant starch. Clin Nutr. 2012;31:60–4. https://doi.org/10.1016/j.
clnu.2011.09.003.
102. Biasi F, Mascia C, Poli G.The contribution of animal fat oxidation products to colon carcinogenesis, through modulation of
Role ofLifestyle Modication andDiet inthePrevention ofCancer
https://t.me/medicina_free
159
TGF-β1 signaling. Carcinogenesis. 2008;29(5):890–4. https://doi.
org/10.1093/carcin/bgn106.
103. Sugimura T, Wakabayashi K, Nakagama H, Nagao
M.Heterocyclic amines: mutagens/carcinogens produced during
cooking of meat and sh. Cancer Sci. 2004;95:290–9. https://doi.
org/10.1111/j.1349- 7006.2004.tb03205.x.
104. Velmurugan B, Gangar SC, Kaur M, Tyagi A, Deep G, Agarwal
R. Silibinin exerts sustained growth suppressive effect against
human colon carcinoma SW480 xenograft by targeting multiple
signaling molecules. Pharm Res. 2010;27(10):2085–97. https://
doi.org/10.1007/s11095- 010- 0207- 6.
105. Rajamanickam S, Agarwal R.Natural products and colon cancer:
current status and future prospects. Drug Dev Res. 2008;69:460–
71. https://doi.org/10.1002/ddr.20276.
106. Ye SF, Hou ZQ, Zhong LM, Zhang QQ.Effect of curcumin on
the induction of glutathione S-transferases and NADP(H):quinone
oxidoreductase and its possible mechanism of action. Yao XueXue
Bao. 2007;42:376–80.
107. Yogosawa S, Yamada Y, Yasuda S, Sun Q, Takizawa K, Sakai
T.Dehydrozingerone, a structural analogue of curcumin, induces
cell-cycle arrest at the G2/M phase and accumulates intracellular ROS in HT-29 human colon cancer cells. J Nat Prod.
2012;75(12):2088–93. https://doi.org/10.1021/np300465f.
108. Khan N, Mukhtar H. Multitargeted therapy of cancer by green
tea polyphenols. Cancer Lett. 2008;269(2):269–80. https://doi.
org/10.1016/j.canlet.2008.04.014.
109. Larsen CA, Dashwood RH. (-)-Epigallocatechin-3-gallate inhibits Met signaling, proliferation, and invasiveness in human colon
cancer cells. Arch Biochem Biophys. 2010;501(1):52–7. https://
doi.org/10.1016/j.abb.2010.03.017.
110. Thakur VS, Ruhul Amin AR, Paul RK, Gupta K, Hastak K,
Agarwal MK, Jackson MW, Wald DN, Mukhtar H, Agarwal
ML. p53-Dependent p21-mediated growth arrest pre-empts
and protects HCT116 cells from PUMA-mediated apoptosis
induced by EGCG.Cancer Lett. 2010;296(2):225–32. https://doi.
org/10.1016/j.canlet.2010.04.012.
111. Chen X, Kokkotou EG, Mustafa N, Bhaskar KR, Sougioultzis
S, O'Brien M, Pothoulakis C, Kelly CP. Saccharomyces boular-
dii inhibits ERK1/2 mitogen-activated protein kinase activation
both invitro and invivo and protects against Clostridium difcile
toxin A-induced enteritis. J Biol Chem. 2006;281(34):24449–54.
https://doi.org/10.1074/jbc.M605200200.
112. Matsumoto M, Kurihara S, Kibe R, Ashida H, Benno Y.Longevity
in mice is promoted by probiotic-induced suppression of colonic
senescence dependent on upregulation of gut bacterial polyamine production. PLoS One. 2011;6(8):e23652. https://doi.
org/10.1371/journal.pone.0023652.
113. Park E, Jeon GI, Park JS, Paik HD.A probiotic strain of Bacillus
polyfermenticus reduces DMH induced precancerous lesions in
F344 male rat. Biol Pharm Bull. 2007;30(3):569–74. https://doi.
org/10.1248/bpb.30.569.
114. Blasiak J, Trzeciak A, Malecka-Panas E, Drzewoski J,
Wojewódzka M.In vitro genotoxicity of ethanol and acetaldehyde
in human lymphocytes and the gastrointestinal tract mucosa cells.
Toxicol In Vitro. 2000;14(4):287–95. https://doi.org/10.1016/
s0887- 2333(00)00022- 9.
115. Leufkens AM, Van Duijnhoven FJ, Siersema PD, Boshuizen HC,
Vrieling A, Agudo A, Gram IT, Weiderpass E, Dahm C, Overvad
K, Tjønneland A, Olsen A, Boutron-Ruault MC, Clavel-Chapelon
F, Morois S, Palli D, Grioni S, Tumino R, Sacerdote C, Mattiello
A, Herman S, Kaaks R, Steffen A, Boeing H, Trichopoulou A,
Lagiou P, Trichopoulos D, Peeters PH, van Gils CH, van Kranen
H, Lund E, Dumeaux V, Engeset D, Rodríguez L, Sánchez
MJ, Chirlaque MD, Barricarte A, Manjer J, Almquist M, van
Guelpen B, Hallmans G, Khaw KT, Wareham N, Tsilidis KK,
Straif K, Leon-Roux M, Vineis P, Norat T, Riboli E, Bueno-de-
Mesquita HB. Cigarette smoking and colorectal cancer risk in
the European Prospective Investigation into Cancer and Nutrition
study. Clin Gastroenterol Hepatol. 2011;9(2):137–44. https://doi.
org/10.1016/j.cgh.2010.10.012.
116. Gutierez DA, Puglisi MJ, Hasty AH.Impact of increased adipose
tissue mass on inammation, insulin resistance, and dyslipidemia. Curr Diab Rep. 2009;9(1):26–32. https://doi.org/10.1007/
s11892- 009- 0006- 9.
117. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer.
2004;4(8):579–91. https://doi.org/10.1038/nrc1408.
118. Cirillo D, Rachiglio AM, la Montagna R, Giordano A, Normanno
N.Leptin signaling in breast cancer: an overview. J Cell Biochem.
2008;105:956–64. https://doi.org/10.1002/jcb.21911.
119. Hrushesky WJ, Lannin D, Haus E.Evidence for an ontogenetic
basis for circadian coordination of cancer cell proliferation.
J Natl Cancer Inst. 1998;90:1480–4. https://doi.org/10.1093/
jnci/90.19.1480.
120. Hashemi SH, Karimi S, Mahboobi H.Lifestyle changes for prevention of breast cancer. Electron Physician. 2014;6(3):894–905.
https://doi.org/10.14661/2014.894- 905.
121. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura
AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL,
Rosenthal JF, Hyer MB.Migration patterns and breast cancer risk
in Asian-American women. J Natl Cancer Inst. 1993;85(22):1819–
27. https://doi.org/10.1093/jnci/85.22.1819.
122. Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ,
Spiegelman D, Barbieri RL, Speizer FE.Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.
J Natl Cancer Inst. 1998;90(17):1292–9. https://doi.org/10.1093/
jnci/90.17.1292.
123. Hirose K, Toyama T, Iwata H, Takezaki T, Hamajima N, Tajima
K. Insulin, insulin-like growth factor and breast cancer risk in
Japanese women. Asian Pac J Cancer Prev. 2003;4(3):239–46.
124. Hamelers IH, Steenbergh PH.Interactions between estrogen and
insulin-like growth factor signaling pathways in human breast
tumor cells. Endocr Relat Cancer. 2003;10(2):331–45. https://doi.
org/10.1677/erc.0.0100331.
125. Demark-Wahnefried W, Jones LW, Snyder DC, Sloane RJ,
Kimmick GG, Hughes DC, Badr HJ, Miller PE, Burke LE, Lipkus
IM.Daughters and mothers against breast cancer (DAMES): main
outcomes of a randomized controlled trial of weight loss in overweight mothers with breast cancer and their overweight daughters. Cancer. 2014;120(16):2522–34. https://doi.org/10.1002/
cncr.28761.
126. Pudrovska T, Anishkin A, Shen Y.Early-life socioeconomic status and the prevalence of breast cancer in later life. Res Aging.
2012;34(3):302–20. https://doi.org/10.1177/0164027511415632.
127. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D.Global
cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. https://doi.
org/10.3322/caac.20107.
128. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108. https://doi.
org/10.3322/canjclin.55.2.74.
129. Lahmann PH, Hoffmann K, Allen N, van Gils CH, Khaw KT,
Tehard B, Berrino F, Tjønneland A, Bigaard J, Olsen A, Overvad
K, Clavel-Chapelon F, Nagel G, Boeing H, Trichopoulos D,
Economou G, Bellos G, Palli D, Tumino R, Panico S, Sacerdote C,
Krogh V, Peeters PH, Bueno-de-Mesquita HB, Lund E, Ardanaz
E, Amiano P, Pera G, Quirós JR, Martínez C, Tormo MJ, Wirfält
E, Berglund G, Hallmans G, Key TJ, Reeves G, Bingham S, Norat
T, Biessy C, Kaaks R, Riboli E.Body size and breast cancer risk:
ndings from the European Prospective Investigation into Cancer
And Nutrition (EPIC). Int J Cancer. 2004;111(5):762–71. https://
doi.org/10.1002/ijc.20315.
160
https://t.me/medicina_free
M. Chatterjee et al.
130. Van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson
L, Folsom AR, Fraser G, Goldbohm RA, Graham S, Kushi L,
Marshall JR, Miller AB, Rohan T, Smith-Warner SA, Speizer
FE, Willett WC, Wolk A, Hunter DJ. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk.
Am J Epidemiol. 2000;152(6):514–27. https://doi.org/10.1093/
aje/152.6.514.
131. Emaus MJ, van Gils CH, Bakker MF, Bisschop CN, Monninkhof
EM, Bueno-de-Mesquita HB, Travier N, Berentzen TL, Overvad
K, Tjønneland A, Romieu I, Rinaldi S, Chajes V, Gunter MJ,
Clavel-Chapelon F, Fagherazzi G, Mesrine S, Chang-Claude J,
Kaaks R, Boeing H, Aleksandrova K, Trichopoulou A, Naska
A, Orfanos P, Palli D, Agnoli C, Tumino R, Vineis P, Mattiello
A, Braaten T, Borch KB, Lund E, Menéndez V, Sánchez MJ,
Navarro C, Barricarte A, Amiano P, Sund M, Andersson A,
Borgquist S, Olsson A, Khaw KT, Wareham N, Travis RC, Riboli
E, Peeters PH, May AM.Weight change in middle adulthood and
breast cancer risk in the EPIC-PANACEA study. Int J Cancer.
2014;135(12):2887–99. https://doi.org/10.1002/ijc.28926.
132. Travier N, Fonseca-Nunes A, Javierre C, Guillamo E, Arribas L,
Peiró I, Buckland G, Moreno F, Urruticoechea A, Oviedo GR,
Roca A, Hurtós L, Ortega V, Muñoz M, Garrigós L, Cirauqui B,
Del Barco S, Arcusa A, Seguí MA, Borràs JM, Gonzalez CA,
Agudo A.Effect of a diet and physical activity intervention on
body weight and nutritional patterns in overweight and obese
breast cancer survivors. Med Oncol. 2014;31(1):783. https://doi.
org/10.1007/s12032- 013- 0783- 5.
133. Young A, Weltzien E, Kwan M, Castillo A, Caan B, Kroenke
CH. Pre- to post-diagnosis weight change and associations
with physical functional limitations in breast cancer survivors. J Cancer Surviv. 2014;8:539–47. https://doi.org/10.1007/
s11764- 014- 0356- 4.
134. Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey
JR. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors:
a randomized controlled trial. Cancer Epidemiol Biomark Prev.
2003;12(8):721–7.
135. Irwin ML, Varma K, Alvarez-Reeves M, Cadmus L, Wiley A,
Chung GG, Dipietro L, Mayne ST, Yu H.Randomized controlled
trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale Exercise and Survivorship
study. Cancer Epidemiol Biomark Prev. 2009;18(1):306–13.
https://doi.org/10.1158/1055- 9965.EPI- 08- 0531.
136. Ligibel JA, Campbell N, Partridge A, Chen WY, Salinardi T, Chen
H, Adloff K, Keshaviah A, Winer EP.Impact of a mixed strength
and endurance exercise intervention on insulin levels in breast
cancer survivors. J Clin Oncol. 2008;26(6):907–12. https://doi.
org/10.1200/JCO.2007.12.7357.
137. Bradshaw PT, Ibrahim JG, Khankari N, Cleveland RJ, Abrahamson
PE, Stevens J, Satia JA, Teitelbaum SL, Neugut AI, Gammon
MD. Post-diagnosis physical activity and survival after breast
cancer diagnosis: the Long Island Breast Cancer Study. Breast
Cancer Res Treat. 2014;145(3):735–42. https://doi.org/10.1007/
s10549- 014- 2966- y.
138. Schmid D, Leitzmann MF.Association between physical activity and mortality among breast cancer and colorectal cancer
survivors: a systematic review and meta-analysis. Ann Oncol.
2014;25(7):1293–311. https://doi.org/10.1093/annonc/mdu012.
139. Avraham Z, Baron-Epel O, Boker LK.The relationship between
passive smoking, breast cancer risk and n-acetyltransferase 2
(NAT2). Harefuah. 2014;153(3-4):171–5, 238.
140. Dossus L, Boutron-Ruault MC, Kaaks R, Gram IT, Vilier A, Fervers
B, Manjer J, Tjonneland A, Olsen A, Overvad K, Chang-Claude
J, Boeing H, Steffen A, Trichopoulou A, Lagiou P, Sarantopoulou
M, Palli D, Berrino F, Tumino R, Vineis P, Mattiello A, Bueno-
de- Mesquita HB, van Duijnhoven FJ, Bakker MF, Peeters PH,
Weiderpass E, Bjerkaas E, Braaten T, Menéndez V, Agudo A,
Sanchez MJ, Amiano P, Tormo MJ, Barricarte A, Butt S, Khaw
KT, Wareham N, Key TJ, Travis RC, Rinaldi S, McCormack V,
Romieu I, Cox DG, Norat T, Riboli E, Clavel-Chapelon F.Active
and passive cigarette smoking and breast cancer risk: results from
the EPIC cohort. Int J Cancer. 2014;134(8):1871–88.
141. Ilic M, Vlajinac H, Marinkovic J. Cigarette smoking and
breast cancer: a case-control study in Serbia. Asian Pac J
Cancer Prev. 2013;14(11):6643–7. https://doi.org/10.7314/
apjcp.2013.14.11.6643.
142. Kawai M, Malone KE, Tang MT, Li CI.Active smoking and the
risk of estrogen receptor-positive and triple-negative breast cancer
among women ages 20 to 44 years. Cancer. 2014;120(7):1026–34.
https://doi.org/10.1002/cncr.28402.
143. Rosenberg L, Boggs DA, Bethea TN, Wise LA, AdamsCampbell LL, Palmer JR. A prospective study of smoking and
breast cancer risk among African-American women. Cancer
Causes Control. 2013;24(12):2207–15. https://doi.org/10.1007/
s10552- 013- 0298- 6.
144. Bishop JD, Killelea BK, Chagpar AB, Horowitz NR, Lannin
DR.Smoking and breast cancer recurrence after breast conservation therapy. Int J Breast Cancer. 2014;2014:327081. https://doi.
org/10.1155/2014/327081.
145. Liu Y, Colditz GA, Rosner B, Berkey CS, Collins LC, Schnitt
SJ, Connolly JL, Chen WY, Willett WC, Tamimi RM. Alcohol
intake between menarche and rst pregnancy: a prospective study
of breast cancer risk. J Natl Cancer Inst. 2013;105(20):1571–8.
https://doi.org/10.1093/jnci/djt213.
146. McDonald JA, Goyal A, Terry MB.Alcohol intake and breast cancer risk: weighing the overall evidence. Curr Breast Cancer Rep.
2013;5(3):114. https://doi.org/10.1007/s12609- 013- 0114- z.
147. Scoccianti C, Lauby-Secretan B, Bello PY, Chajes V, Romieu
I. Female breast cancer and alcohol consumption: a review of
the literature. Am J Prev Med. 2014;46(3):S16–25. https://doi.
org/10.1016/j.amepre.2013.10.031.
148. Islam T, Ito H, Sueta A, Hosono S, Hirose K, Watanabe M, Iwata
H, Tajima K, Tanaka H, Matsuo K. Alcohol and dietary folate
intake and the risk of breast cancer: a case-control study in Japan.
Eur J Cancer Prev. 2013;22(4):358–66. https://doi.org/10.1097/
CEJ.0b013e32835b6a60.
149. Boyd NF, Stone J, Vogt KN, Connelly BS, Martin LJ, Minkin
S.Dietary fat and breast cancer risk revisited: a meta-analysis of
the published literature. Br J Cancer. 2003;89(9):1672–85. https://
doi.org/10.1038/sj.bjc.6601314.
150. Ganmaa D, Willett WC, Li TY, Feskanich D, van Dam RM,
Lopez-Garcia E, Hunter DJ, Holmes MD. Coffee, tea, caffeine
and risk of breast cancer: a 22-year follow-up. Int J Cancer.
2008;122(9):2071–6. https://doi.org/10.1002/ijc.23336.
151. Ishitani K, Lin J, Manson JE, Buring JE, Zhang SM. Caffeine
consumption and the risk of breast cancer in a large prospective cohort of women. Arch Intern Med. 2008;168(18):2022–31.
https://doi.org/10.1001/archinte.168.18.2022.
152. Taylor EF, Burley VJ, Greenwood DC, Cade JE. Meat consumption and risk of breast cancer in the UK Women’s Cohort
Study. Br J Cancer. 2007;96(7):1139–46. https://doi.org/10.1038/
sj.bjc.6603689.
153. Shin MH, Holmes MD, Hankinson SE, Wu K, Colditz GA, Willett
WC.Intake of dairy products, calcium, and vitamin d and risk of
breast cancer. J Natl Cancer Inst. 2002;94(17):1301–11. https://
doi.org/10.1093/jnci/94.17.1301.
154. Stuebe AM, Willett WC, Xue F, Michels KB.Lactation and incidence of premenopausal breast cancer: a longitudinal study. Arch
Intern Med. 2009;169(15):1364–71. https://doi.org/10.1001/
archinternmed.2009.231.
Role ofLifestyle Modication andDiet inthePrevention ofCancer
https://t.me/medicina_free
161
155. Zheng T, Holford TR, Mayne ST, Owens PH, Zhang Y, Zhang
B, Boyle P, Zahm SH. Lactation and breast cancer risk: a casecontrol study in Connecticut. Br J Cancer. 2001;84(11):1472–6.
https://doi.org/10.1054/bjoc.2001.1793.
156. Schernhammer ES, Hankinson SE. Urinary melatonin levels
and breast cancer risk. J Natl Cancer Inst. 2005;97(14):1084–7.
https://doi.org/10.1093/jnci/dji190.
157. Schernhammer ES, Hankinson SE.Urinary melatonin levels and
postmenopausal breast cancer risk in the Nurses’ Health Study
cohort. Cancer Epidemiol Biomark Prev. 2009;18(1):74–9. https://
doi.org/10.1158/1055- 9965.EPI- 08- 0637.
158. Wang L, Liao WC, Tsai CJ, Wang LR, Mao IF, Chen CC, Kao PF,
Yao CC.The effects of perceived stress and life style leading to
breast cancer. Women Health. 2013;53(1):20–40. https://doi.org/1
0.1080/03630242.2012.732680.
159. Agrawal A, Fentiman IS.NSAIDs and breast cancer: a possible prevention and treatment strategy. Int J Clin Pract. 2008;62(3):444–9.
https://doi.org/10.1111/j.1742- 1241.2007.01668.x.
160. Kwan ML, Habel LA, Slattery ML, Caan B. NSAIDs and
breast cancer recurrence in a prospective cohort study. Cancer
Causes Control. 2007;18(6):613–20. https://doi.org/10.1007/
s10552- 007- 9003- y.
161. Zhao YS, Zhu S, Li XW, Wang F, Hu FL, Li DD, Zhang WC,
Li X. Association between NSAIDs use and breast cancer risk:
a systematic review and meta-analysis. Breast Cancer Res Treat.
2009;117(1):141–50. https://doi.org/10.1007/s10549- 008- 0228- 6.
162. Ahern TP, Lash TL, Sorensen HT, Pedersen L. Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study. Breast Cancer Res.
2008;10(6):R102. https://doi.org/10.1186/bcr2205.
163. Ahern TP, Tamimi RM, Rosner BA, Hankinson SE.Digoxin use
and risk of invasive breast cancer: evidence from the Nurses’
Health Study and meta-analysis. Breast Cancer Res Treat.
2014;144(2):427–35. https://doi.org/10.1007/s10549- 014- 2886- x.
164. Biggar RJ, Wohlfahrt J, Oudin A, Hjuler T, Melbye
M. Digoxin use and the risk of breast cancer in women. J
Clin Oncol. 2011;29(16):2165–70. https://doi.org/10.1200/
JCO.2010.32.8146.
165. Egawa G, Kabashima K. Skin as a peripheral lymphoid organ:
revisiting the concept of skin-associated lymphoid tissues. J
Investig Dermatol. 2011;131:2178–85. https://doi.org/10.1038/
jid.2011.198.
166. Kabashima K, Honda T, Ginhoux F, Egawa G.The immunological
anatomy of the skin. Nat Rev Immunol. 2019;19:19–30. https://
doi.org/10.1038/s41577- 018- 0084- 5.
167. Rigel DS.Cutaneous ultraviolet exposure and its relationship to
the development of skin cancer. J Am Acad Dermatol. 2008;58(5
Suppl 2):S129–32. https://doi.org/10.1016/j.jaad.2007.04.034.
168. Sawada Y, Nakamura M.Daily lifestyle and cutaneous malignancies. Int J Mol Sci. 2021;22(10):5227. https://doi.org/10.3390/
ijms22105227.
169. Schernhammer ES, Razavi P, Li TY, Qureshi AA, Han J.Rotating
night shifts and risk of skin cancer in the nurses’ health study.
J Natl Cancer Inst. 2011;103(7):602–6. https://doi.org/10.1093/
jnci/djr044.
170. Yousef E, Mitwally N, Noufal N, Tahir MR.Shift work and risk
of skin cancer: a systematic review and meta-analysis. Sci Rep.
2020;10:2012. https://doi.org/10.1038/s41598- 020- 59035- x.
171. Dusingize JC, Olsen CM, Pandeya N, Thompson BS, Webb PM,
Green AC, Neale RE, Whiteman DC, Skin Study Q.Smoking and
cutaneous melanoma: ndings from the QSkin Sun and Health
Cohort Study. Cancer Epidemiol Biomark Prev. 2018;27(8):874–
81. https://doi.org/10.1158/1055- 9965.epi- 17- 1056.
172. Hughes MC, Olsen CM, Williams GM, Green AC. A prospective study of cigarette smoking and basal cell carcinoma. Arch
Dermatol Res. 2014;306(9):851–6. https://doi.org/10.1007/
s00403- 014- 1503- 5.
173. Sondermeijer L, Lamboo LGE, de Waal AC, Galesloot TE,
Kiemeney LALM, van Rossum M, Aben KH. Cigarette smoking and the risk of cutaneous melanoma: a case- control
study. Dermatology. 2020;236(3):228–36. https://doi.
org/10.1159/000502129.
174. Gęgotek A, Ambrożewicz E, Jastrząb A, Jarocka-Karpowicz
I, Skrzydlewska E. Rutin and ascorbic acid cooperation in
antioxidant and antiapoptotic effect on human skin keratinocytes and broblasts exposed to UVA and UVB radiation. Arch
Dermatol Res. 2019;311(3):203–19. https://doi.org/10.1007/
s00403- 019- 01898- w.
175. Gęgotek A, Jarocka-Karpowicz I, Skrzydlewska E. Synergistic
cytoprotective effects of rutin and ascorbic acid on the proteomic
prole of 3D-cultured keratinocytes exposed to UVA or UVB
radiation. Nutrients. 2019;11(11):2672. https://doi.org/10.3390/
nu11112672.
176. Jin GH, Liu Y, Jin SZ, Liu XD, Liu SZ. UVB induced oxidative
stress in human keratinocytes and protective effect of antioxidant
agents. Radiat Environ Biophys. 2007;46(1):61–8. https://doi.
org/10.1007/s00411- 007- 0096- 1.
177. Maalouf S, El-Sabban M, Darwiche N, Gali-Muhtasib
H. Protective effect of vitamin E on ultraviolet B light-induced
damage in keratinocytes. Mol Carcinog. 2002;34(3):121–30.
https://doi.org/10.1002/mc.10055.
178. Offord EA, Gautier JC, Avanti O, Scaletta C, Runge F, Krämer K,
Applegate LA.Photoprotective potential of lycopene, β-carotene,
vitamin E, vitamin C and carnosic acid in UVA-irradiated human
skin broblasts. Free Radic Biol Med. 2002;32(12):1293–303.
https://doi.org/10.1016/s0891- 5849(02)00831- 6.
179. Caini S, Boniol M, Tosti G, Magi S, Medri M, Stanganelli I, Palli
D, Assedi M, Marmol VD, Gandini S.Vitamin D and melanoma
and non-melanoma skin cancer risk and prognosis: a comprehensive review and meta-analysis. Eur J Cancer. 2014;50(15):2649–
58. https://doi.org/10.1016/j.ejca.2014.06.024.
180. Lim A, Shayan R, Varigos G. High serum vitamin D level correlates with better prognostic indicators in primary melanoma: a
pilot study. Australas J Dermatol. 2018;59(3):182–7. https://doi.
org/10.1111/ajd.12648.
181. Moreno-Arrones OM, Zegeer J, Gerbo M, Manrique-Silva E,
Requena C, Traves V, Nagore E.Decreased vitamin D serum levels at melanoma diagnosis are associated with tumor ulceration
and high tumor mitotic rate. Melanoma Res. 2019;29(6):664–7.
https://doi.org/10.1097/cmr.0000000000000638.
182. Singh T, Katiyar SK. Green tea catechins reduce invasive
potential of human melanoma cells by targeting COX-2, PGE2
receptors and epithelial-to-mesenchymal transition. PLoS
One. 2011;6(10):e25224. https://doi.org/10.1371/journal.
pone.0025224.
183. Vaid M, Singh T, Katiyar S.Grape seed proanthocyanidins inhibit
melanoma cell invasiveness by reduction of PGE2 synthesis and
reversal of epithelial-to-mesenchymal transition. PLoS One.
2011;6(6):e21539. https://doi.org/10.1371/journal.pone.0021539.
184. Singh T, Vaid M, Katiyar N, Sharma S, Katiyar SK.Berberine, an
isoquinoline alkaloid, inhibits melanoma cancer cell migration by
reducing the expressions of cyclooxygenase-2, prostaglandin E2
and prostaglandin E2 receptors. Carcinogenesis. 2011;32(1):86–
92. https://doi.org/10.1093/carcin/bgq215.
185. Kim KM, Im AR, Kim SH, Hyun JW, Chae S.Timosaponin AIII
inhibits melanoma cell migration by suppressing COX-2 and
invivo tumor metastasis. Cancer Sci. 2016;107(2):181–8. https://
doi.org/10.1111/cas.12852.
186. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack
TM.Cancers of the prostate and breast among Japanese and white
162
https://t.me/medicina_free
M. Chatterjee et al.
immigrants in Los Angeles County. Br J Cancer. 1991;63(6):963–
6. https://doi.org/10.1038/bjc.1991.210.
187. Hsing AW, Tsao L, Devesa SS. International trends
and patterns of prostate cancer incidence and mortality. Int J Cancer. 2000;85(1):60–7. https://doi.org/10.1002/
(sici)1097- 0215(20000101)85:1<60::aid- ijc11>3.0.co;2- b.
188. Hebert JR, Hurley TG, Olendzki BC, Teas J, Ma Y, Hampl
JS. Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. J Natl Cancer Inst.
1998;90(21):1637–47. https://doi.org/10.1093/jnci/90.21.1637.
189. Moyad MA.Dietary fat reduction to reduce prostate cancer risk:
controlled enthusiasm, learning a lesson from breast or other cancers, and the big picture. Urology. 2002;59(4):51–62. https://doi.
org/10.1016/s0090- 4295(01)01176- 1.
190. Moyad MA. Lifestyle/dietary supplement partial androgen suppression and/or estrogen manipulation: a novel PSA reducer
and preventive/treatment option for prostate cancer? Urol
Clin North Am. 2002;29(1):115–24. https://doi.org/10.1016/
s0094- 0143(02)00037- x.
191. Bartsch H, Nair J, Owen RW.Dietary polyunsaturated fatty acids
and cancers of the breast and colorectum: emerging evidence for
their role as risk modiers. Carcinogenesis. 1999;20(12):2209–
18. https://doi.org/10.1093/carcin/20.12.2209.
192. Thune I, Furberg AS. Physical activity and cancer risk:
dose-response and cancer, all sites and site-specic.
Med Sci Sports Exerc. 2001;33(6):530–50. https://doi.
org/10.1097/00005768- 200106001- 00025.
193. Tymchuk CN, Barnard RJ, Heber D, Aronson WJ. Evidence of
an inhibitory effect of diet and exercise on prostate cancer cell
growth. J Urol. 2001;166(3):1185–9.
194. Ngo TH, Barnard RJ, Leung P-S, Cohen P, Aronson WJ.Insulinlike growth factor I (IGF-I) and IGF binding protein-1 modulate
prostate cancer cell growth and apoptosis: possible mediators for the
effects of diet and exercise on cancer cell survival. Endocrinology.
2003;144(6):2319–24. https://doi.org/10.1210/en.2003- 221028.
195. Tymchuk CN, Tessler SB, Aronson WJ, Barnard RJ. Effects of
diet and exercise on insulin, sex hormone-binding globulin,
and prostate-specic antigen. Nutr Cancer. 1998;31(2):127–31.
https://doi.org/10.1080/01635589809514691.
196. Tymchuk CN, Barnard RJ, Ngo TH, Aronson WJ. The role of
testosterone, estradiol, and insulin in diet and exercise-induced
reductions in prostate cancer cell growth in vitro. Nutr Cancer.
2002;42(1):112–6. https://doi.org/10.1207/S15327914NC421_15.
197. Barnard RJ, Aronson WJ, Tymchuk CN, Ngo TH. Prostate
cancer: another aspect of the insulin- resistance syndrome? Obes Rev. 2002;3(4):303–8. https://doi.
org/10.1046/j.1467- 789x.2002.00081.x.
198. LeRoith D, Roberts CT Jr. The insulin-like growth factor system and cancer. Cancer Lett. 2003;195:127–37. https://doi.
org/10.1016/s0304- 3835(03)00159- 9.
199. Ngo TH, Barnard RJ, Tymchuk CN, Cohen P, Aronson WJ.Effect
of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro. Cancer Causes Control.
2002;13(10):929–35. https://doi.org/10.1023/a:1021911517010.
200. Gurumurthy S, Vasudevan KM, Rangnekar VM.Regulation of
apoptosis in prostate cancer. Cancer Metastasis Rev. 2001;20(3-
4):225–43. https://doi.org/10.1023/a:1015583310759.
201. Barnard RJ, Ngo TH, Leung P-S, Aronson WJ, Golding LA.A
Low-fat diet and/or strenuous exercise alters the IGF axis invivo
and reduces prostate tumor cell growth in vitro. Prostrate.
2003;56(3):201–6. https://doi.org/10.1002/pros.10251.
202. Leung P-S, Aronson WJ, Ngo TH, Golding LA, Barnard
RJ.Exercise alters the IGF axis in vivo and increases p53 protein
in prostate tumor cells in vitro. J Appl Physiol. 2004;96:450–4.
https://doi.org/10.1152/japplphysiol.00871.2003.
203. Ornish D, Lee KL, Fair WR, Pettengill EB, Carroll PR.Dietary
trial in prostate cancer: early experience and implications for
clinical trial design. Urology. 2001;57(4):200–1. https://doi.
org/10.1016/s0090- 4295(00)00974- 2.
204. Ornish D, Weidner G, Fair WR, Marlin R, Pettengill EB, Raisin
CJ, Dunn-Emke S, Crutcheld L, Jacobs FN, Barnard RJ,
Aronson WJ, McCormac P, McKnight DJ, Fein JD, Dnistrian
AM, Weinstein J, Ngo TH, Mendell NR, Carroll PR.Intensive
lifestyle changes may affect the progression of prostate cancer. J Urol. 2005;174(3):1065–70. https://doi.org/10.1097/01.
ju.0000169487.49018.73.
205. Boileau TW, Liao Z, Kim S, Lemeshow S, Erdman JW Jr, Clinton
SK.Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)testosterone-treated rats fed tomato powder, lycopene, or energyrestricted diets. J Natl Cancer Inst. 2003;95(21):1578–86. https://
doi.org/10.1093/jnci/djg081.
206. Chen L, Stacewicz-Sapuntzakis M, Duncan C, Shari R, Ghosh L,
van Breemen R, Ashton D, Bowen PE.Oxidative DNA damage in
prostate cancer patients consuming tomato sauce-based entrees as
a whole-food intervention. J Natl Cancer Inst. 2001;93(24):1872–
9. https://doi.org/10.1093/jnci/93.24.1872.
207. Mucci LA, Tamimi R, Lagiou P, Trichopoulou A, Benetou V,
Spanos E, Trichopoulos D. Are dietary inuences on the risk
of prostate cancer mediated through the insulin-like growth
factor system? BJU Int. 2001;87(9):814–20. https://doi.
org/10.1046/j.1464- 410x.2001.02191.x.
208. Hsing AW, Chokkalingam AP, Gao YT, Madigan MP, Deng
J, Gridley G, Fraumeni JF Jr. Allium vegetables and risk of
prostate cancer: a population-based study. J Natl Cancer Inst.
2002;94(21):1648–51. https://doi.org/10.1093/jnci/94.21.1648.
209. Kristal AR, Lampe JW. Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence. Nutr Cancer.
2002;42(1):1–9. https://doi.org/10.1207/S15327914NC421_1.
210. Moyad MA.The ABCs of nutrition and supplements for prostate
cancer. Ann Arbor: JW Edwards Publishing; 2000.
211. Moyad MA, Carroll PR. Lifestyle recommendations to prevent prostate cancer, part II: time to redirect our attention?
Urol Clin N Am. 2004;31(2):301–11. https://doi.org/10.1016/j.
ucl.2004.03.007.
212. Nagata C, Inaba S, Kawakami N, Kakizoe T, Shimizu H.Inverse
association of soy product intake with serum androgen and estrogen concentrations in Japanese men. Nutr Cancer. 2000;36(1):14–
8. https://doi.org/10.1207/S15327914NC3601_3.
213. Dabrosin C, Chen J, Wang L, Thompson LU. Flaxseed inhibits metastasis and decreases extracellular vascular endothelial growth factor in human breast cancer xenografts.
Cancer Lett. 2002;185(1):31–7. https://doi.org/10.1016/
s0304- 3835(02)00239- 2.
214. Schuurman AG, van den Brandt PA, Dorant E, Brants HA,
Goldbohm RA.Association of energy and fat intake with prostate carcinoma risk: results from The Netherlands Cohort Study.
Cancer. 1999;86(6):1019–27.
215. Demark-Wahnefried W, Price DT, Polascik TJ, Robertson CN,
Anderson EE, Paulson DF, Walther PJ, Gannon M, Vollmer
RT.Pilot study of dietary fat restriction and axseed supplementation in men with prostate cancer before surgery: exploring the
effects on hormonal levels, prostate-specic antigen, and histopathologic features. Urology. 2001;58(1):47–52. https://doi.
org/10.1016/s0090- 4295(01)01014- 7.
216. Aronson WJ, Glaspy JA, Reddy ST, Reese D, Heber D,
Bagga D. Modulation of omega-3/omega-6 polyunsaturated ratios with dietary sh oils in men with prostate cancer. Urology. 2001;58(2):283–8. https://doi.org/10.1016/
s0090- 4295(01)01116- 5.
217. Chung BH, Mitchell SH, Zhang SS, Young CY.Effects of docosahexaenoic acid and eicosapentaenoic acid on androgen-mediated
Role ofLifestyle Modication andDiet inthePrevention ofCancer
https://t.me/medicina_free
163
cell growth and gene expression in LNCaP prostate cancer cells.
Carcinogenesis. 2001;22(8):1201–6. https://doi.org/10.1093/
carcin/22.8.1201.
218. Terry P, Lichtenstein P, Feychting M, Ahlbom A, Wolk
A. Fatty sh consumption and risk of prostate cancer.
Lancet. 2001;357(9270):1764–6. https://doi.org/10.1016/
S0140- 6736(00)04889- 3.
219. Augustsson K, Michaud DS, Rimm EB, Leitzmann MF, Stampfer
MJ, Willett WC, Giovannucci E.A prospective study of intake of
sh and marine fatty acids and prostate cancer. Cancer Epidemiol
Biomark Prev. 2003;12(1):64–7.
220. Albert CM, Gaziano JM, Willett WC, Manson JE.Nut consumption and decreased risk of sudden cardiac death in the physicians’
health study. Arch Intern Med. 2002;162:1382–7. https://doi.
org/10.1001/archinte.162.12.1382.
221. Friedenreich CM.Physical activity and cancer prevention: from
observational to intervention research. Cancer Epidemiol Biomark
Prev. 2001;10:287–301.
222. Babyak M, Blumenthal JA, Herman S, Khatri P, Doraiswamy M,
Moore K, Craighead WE, Baldewicz TT, Krishnan KR.Exercise
treatment for major depression: maintenance of therapeutic benet at 10 months. Psychosom Med. 2000;62(5):633–8. https://doi.
org/10.1097/00006842- 200009000- 00006.
223. Plaskon LA, Penson DF, Vaughan TL, Stanford JL. Cigarette
smoking and risk of prostate cancer in middle-aged men. Cancer
Epidemiol Biomark Prev. 2003;12(7):604–9.
224. Roberts WW, Platz EA, Walsh PC. Association of cigarette smoking with extraprostatic prostate cancer in young
men. J Urol. 2003;169:512–6. https://doi.org/10.1097/01.
ju.0000046160.80804.7f.
225. Rodriguez C, Tatham LM, Thun MJ, Calle EE, Heath CW Jr.
Smoking and fatal prostate cancer in a large cohort of adult men.
Am J Epidemiol. 1997;145:466–75. https://doi.org/10.1093/
oxfordjournals.aje.a009129.
226. Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willett WC,
Giovannucci EL.Zinc supplement use and risk of prostate cancer.
J Natl Cancer Inst. 2003;95(13):1004–7. https://doi.org/10.1093/
jnci/95.13.1004.
227. Choi JW, Hua TNM.Impact of lifestyle behaviors on cancer risk
and prevention. J Lifestyle Med. 2021;11(1):1–7. https://doi.
org/10.15280/jlm.2021.11.1.1.
228. Porro C, La Torre ME, Tartaglia N, Benameur T, Santini M,
Ambrosi A, Messina G, Cibelli G, Fiorelli A, Polito R, Messina
G. The potential role of nutrition in lung cancer establishment
and progression. Life. 2022;12(2):270. https://doi.org/10.3390/
life12020270.
229. Halliwell B, Gutteridge J.Free radicals in biology and medicine.
4th ed. Oxford: Oxford University; 2007.
230. Afonso V, Champy R, Mitrovic D, Collin P, Lomri A. Reactive
oxygen species and superoxide dismutases: role in joint diseases. J Bone Spine. 2007;74:324–9. https://doi.org/10.1016/j.
jbspin.2007.02.002.
231. Filaire E, Dupuis C, Galvaing G, Aubreton S, Laurent H, Richard
R, Filaire M.Lung cancer: what are the links with oxidative stress,
physical activity and nutrition. Lung Cancer. 2013;82:383–9.
https://doi.org/10.1016/j.lungcan.2013.09.009.
232. Weinberg RA.The biology of cancer. NewYork: Garland Science;
2006.
233. Hannan MA, Recio L, Deluca PP, Enoch H.Co-mutagenic effects
of 2-aminoanthracene and cigarette smoke condensate on smoker’s urine in the Ames Salmonella assay system. Cancer Lett.
1981;13:203–12. https://doi.org/10.1016/0304- 3835(81)90019- 7.
234. Lee J, Taneja V, Vassallo R.Cigarette smoking and inammation:
cellular and molecular mechanisms. J Dent Res. 2012;91:142–9.
https://doi.org/10.1177/0022034511421200.
235. Møller P, Folkmann JK, Forchhammer L, Bräuner EV, Danielsen
PH, Risom L, Loft S.Air pollution, oxidative damage to DNA,
and carcinogenesis. Cancer Lett. 2008;266:84–97. https://doi.
org/10.1016/j.canlet.2008.02.030.
236. Pryor WA. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ Health Perspect.
1997;105(4):875–82. https://doi.org/10.1289/ehp.97105s4875.
237. Sangani RG, Ghio AJ.Lung injury after cigarette smoking is particle related. Int J Chron Obstruct Pulmon Dis. 2011;6:191–8.
https://doi.org/10.2147/COPD.S14911.
238. Goldkorn T, Filosto S, Chung S. Lung injury and lung cancer
caused by cigarette smoke-induced oxidative stress: molecular mechanisms and therapeutic opportunities involving the
ceramide-generating machinery and epidermal growth factor
receptor. Antioxid Redox Signal. 2014;15:2149–74. https://doi.
org/10.1089/ars.2013.5469.
239. Wang RP, Wang XH, Li ZM, Sun JR. Changes in serum
inammatory factors, adiponectin, intestinal ora and immunity in patients with non-small cell lung cancer. Eur Rev Med
Pharmacol Sci. 2020;24:10566–72. https://doi.org/10.26355/
eurrev_202010_23412.
240. Wei X, Zhu C, Ji M, Fan J, Xie J, Huang Y, Jiang X, Xu J, Yin
R, Du L, Wang Y, Dai J, Jin G, Xu L, Hu Z, Shen H, Zhu M, Ma
H.Diet and risk of incident lung cancer: a large prospective cohort
study in UK Biobank. Am J Clin Nutr. 2021;114(6):2043–51.
https://doi.org/10.1093/ajcn/nqab298.
241. Widiatmaja DM, Lutvyani A, Sari DR, Kurniasari H, Meiliana ID,
Fasitasari M, Yamaoka Y, Rejeki PS.The effect of long-term ketogenic diet on serum adiponectin and insulin-like growth factor-1
levels in mice. J Basic Clin Physiol Pharmacol. 2021;33(5):611–8.
https://doi.org/10.1515/jbcpp- 2021- 0287.
242. Atazadegan MA, Bagherniya M, Fakheran O, Sathyapalan
T, Sahebkar A. The effect of herbal medicine and natural bioactive compounds on plasma adiponectin: a clinical
review. Adv Exp Med Biol. 2021;1328:37–57. https://doi.
org/10.1007/978- 3- 030- 73234- 9_4.
243. Singh RB, Niaz MA, Ghosh S, Beegum R, Bishnoi I, Agarwal
P, Agarwal A. Dietary intake and plasma levels of antioxidant vitamins in health and disease. A hospital based case control study. J Nutr Environ Med. 1995;5:235–42. https://doi.
org/10.3109/13590849509000224.
244. Martínez-González MA, Trichopoulou A. Observational epidemiology, lifestyle, and health: the paradigm of the mediterranean
diet. Am J Health Promot. 2020;34(8):948–50. https://doi.org/10.
1177/0890117120960580c.
245. Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges
G, Crozier A.Dietary (poly)phenolics in human health: structures,
bioavailability, and evidence of protective effects against chronic
diseases. Antioxid Redox Signal. 2013;18(14):1818–92. https://
doi.org/10.1089/ars.2012.4581.
246. Ghiselli A, Nardini M, Baldi A, Scaccini C.Antioxidant activity
of different phenolic fractions separated from an Italian red wine.
J Agric Food Chem. 1998;46(2):361–7. https://doi.org/10.1021/
jf970486b.
247. Godos J, Sinatra D, Blanco I, Mulè S, La Verde M, Marranzano
M.Association between dietary phenolic acids and hypertension
in a mediterranean cohort. Nutrients. 2017;9(10):1069. https://doi.
org/10.3390/nu9101069.
248. Nani A, Belarbi M, Ksouri-Megdiche W, Abdoul-Azize S,
Benammar C, Ghiringhelli F, Hichami A, Khan NA. Effects
of polyphenols and lipids from Pennisetumglaucum grains on
T-cell activation: modulation of Ca(2+) and ERK1/ERK2 signaling. BMC Complement Altern Med. 2015;15:426. https://doi.
org/10.1186/s12906- 015- 0946- 3.
249. Liao BC, Hsieh CW, Liu YC, Tzeng TT, Sun YW, Wung
BS. Cinnamaldehyde inhibits the tumor necrosis factor-alpha-
164
https://t.me/medicina_free
M. Chatterjee et al.
induced expression of cell adhesion molecules in endothelial cells
by suppressing NF-kappaB activation: effects upon IkappaB and
Nrf2. Toxicol Appl Pharmacol. 2008;229(2):161–71. https://doi.
org/10.1016/j.taap.2008.01.021.
250. Halliwell B. Antioxidant and anti-inammatory components of
foods. Washington: ILSI International Life Sciences Institute;
2015.
251. Gorlova OY, Weng SF, Hernandez L, Spitz MR, Forman
MR. Dietary patterns affect lung cancer risk in never smokers.
Nutr Cancer. 2011;63(6):842–9. https://doi.org/10.1080/0163558
1.2011.589958.
252. Holick CN, Michaud DS, Stolzenberg-Solomon R, Mayne ST,
Pietinen P, Taylor PR, Virtamo J, Albanes D.Dietary carotenoids,
serum beta-carotene, and retinol and risk of lung cancer in the
alpha-tocopherol, beta-carotene cohort study. Am J Epidemiol.
2002;156(6):536–47. https://doi.org/10.1093/aje/kwf072.
253. Smith-Warner SA, Spiegelman D, Yaun SS, Albanes D, Beeson
WL, van den Brandt PA, Feskanich D, Folsom AR, Fraser GE,
Freudenheim JL, Giovannucci E, Goldbohm RA, Graham S,
Kushi LH, Miller AB, Pietinen P, Rohan TE, Speizer FE, Willett
WC, Hunter DJ.Fruits, vegetables and lung cancer: a pooled analysis of cohort studies. Int J Cancer. 2003;107(6):1001–11. https://
doi.org/10.1002/ijc.11490.
254. Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P, Bergo
MO. Antioxidants accelerate lung cancer progression in mice.
Sci Transl Med. 2014;6(221):221ra15. https://doi.org/10.1126/
scitranslmed.3007653.
255. Brennan P, Hsu CC, Moullan N, Szeszenia-Dabrowska N,
Lissowska J, Zaridze D, Rudnai P, Fabianova E, Mates D, Bencko
V, Foretova L, Janout V, Gemignani F, Chabrier A, Hall J, Hung
RJ, Boffetta P, Canzian F.Effect of cruciferous vegetables on lung
cancer in patients stratied by genetic status: a mendelian randomisation approach. Lancet. 2005;366(9496):1558–60. https://
doi.org/10.1016/S0140- 6736(05)67628- 3.
256. Keck AS, Finley JW. Cruciferous vegetables: cancer protective mechanisms of glucosinolate hydrolysis products and
selenium. Integr Cancer Ther. 2004;3(1):5–12. https://doi.
org/10.1177/1534735403261831.
257. Camarena V, Wang G.The epigenetic role of vitamin C in health
and disease. Cell Mol Life Sci. 2016;73(8):1645–58. https://doi.
org/10.1007/s00018- 016- 2145- x.
258. Liu D, Perkins JT, Hennig B.EGCG prevents PCB-126-induced
endothelial cell inammation via epigenetic modications of
NF-κB target genes in human endothelial cells. J Nutr Biochem.
2016;28:164–70. https://doi.org/10.1016/j.jnutbio.2015.10.003.
259. Shankar E, Kanwal R, Candamo M, Gupta S.Dietary phytochemicals as epigenetic modiers in cancer: promise and challenges.
Semin Cancer Biol. 2016;40-41:82–99. https://doi.org/10.1016/j.
semcancer.2016.04.002.
260. Zhong J, Karlsson O, Wang G, Li J, Guo Y, Lin X, Zemplenyi M,
Sanchez-Guerra M, Trevisi L, Urch B, Speck M, Liang L, Coull
BA, Koutrakis P, Silverman F, Gold DR, Wu T, Baccarelli AA.B
vitamins attenuate the epigenetic effects of ambient ne particles
in a pilot human intervention trial. Proc Natl Acad Sci U S A.
2017;114(13):3503–8. https://doi.org/10.1073/pnas.1618545114.
261. Crider KS, Yang TP, Berry RJ, Bailey LB.Folate and DNA methylation: a review of molecular mechanisms and the evidence for
folate’s role. Adv Nutr. 2012;3(1):21–38. https://doi.org/10.3945/
an.111.000992.
262. Leng S, Picchi MA, Tesfaigzi Y, Wu G, Gauderman WJ, Xu F,
Gilliland FD, Belinsky SA. Dietary nutrients associated with
preservation of lung function in Hispanic and non-Hispanic white
smokers from New Mexico. Int J Chron Obstruct Pulmon Dis.
2017;12:3171–81. https://doi.org/10.2147/COPD.S142237.
263. Leng S, Picchi MA, Kang H, Wu G, Filipczak PT, Juri DE, Zhang
X, Gauderman WJ, Gilliland FD, Belinsky SA.Dietary nutrient
intake, ethnicity, and epigenetic silencing of lung cancer genes
detected in sputum in New Mexican Smokers. Cancer Prev
Res. 2018;11(2):93–102. https://doi.org/10.1158/1940- 6207.
CAPR- 17- 0196.
264. Zhai T, Li S, Hu W, Li D, Leng S. Potential micronutrients and
phytochemicals against the pathogenesis of chronic obstructive
pulmonary disease and lung cancer. Nutrients. 2018;10(7):813.
https://doi.org/10.3390/nu10070813.
265. Soeters PB, Wolfe RR, Shenkin A. Hypoalbuminemia: pathogenesis and clinical signicance. JPEN J Parenter Enteral Nutr.
2019;43(2):181–93. https://doi.org/10.1002/jpen.1451.
266. Roth MJ, Wei WQ, Baer J, Abnet CC, Wang GQ, Sternberg LR,
Warner AC, Johnson LL, Lu N, Giffen CA, Dawsey SM, Qiao YL,
Cherry J.Aryl hydrocarbon receptor expression is associated with
a family history of upper gastrointestinal tract cancer in a high-risk
population exposed to aromatic hydrocarbons. Cancer Epidemiol
Biomark Prev. 2009;18(9):2391–6. https://doi.org/10.1158/1055-
9965.EPI- 08- 1098.
267. Sinha R, Kulldorff M, Curtin J, Brown CC, Alavanja MC,
Swanson CA.Fried, well-done red meat and risk of lung cancer in
women (United States). Cancer Causes Control. 1998;9(6):621–
30. https://doi.org/10.1023/a:1008805525525.
268. Lampe JW.Dairy products and cancer. J Am Coll Nutr. 2011;30(5
Suppl 1):464S–70S. https://doi.org/10.1080/07315724.2011.1071
9991.
269. Thune I, Lund E.The inuence of physical activity on lung-cancer
risk: a prospective study of 81,516 men and women. Int J Cancer.
1997;70(1):57–62.
270. Ziegler RG, Mayne ST, Swanson CA. Nutrition and lung cancer. Cancer Causes Control. 1996;7(1):157–77. https://doi.
org/10.1007/bf00115646.
271. Matthews CE, Moore SC, Arem H, Cook MB, Trabert B,
Håkansson N, Larsson SC, Wolk A, Gapstur SM, Lynch BM,
Milne RL, Freedman ND, Huang WY, Berrington de Gonzalez
A, Kitahara CM, Linet MS, Shiroma EJ, Sandin S, Patel AV, Lee
IM. Amount and intensity of leisure-time physical activity and
lower cancer risk. J Clin Oncol. 2020;38(7):686–97. https://doi.
org/10.1200/jco.19.02407.
272. Chao A, Connell CJ, Jacobs EJ, McCullough ML, Patel AV, Calle
EE, Cokkinides VE, Thun MJ.Amount, type, and timing of recreational physical activity in relation to colon and rectal cancer
in older adults: the Cancer Prevention Study II Nutrition Cohort.
Cancer Epidemiol Biomark Prev. 2004;13(12):2187–95. https://
pubmed.ncbi.nlm.nih.gov/15598779/.
273. Mahmood S, MacInnis RJ, English DR, Karahalios A, Lynch
BM. Domain-specic physical activity and sedentary behaviour
in relation to colon and rectal cancer risk: a systematic review and
meta-analysis. Int J Epidemiol. 2017;46(6):1797–813. https://doi.
org/10.1093/ije/dyx137.
274. Giovannucci E, Leitzmann M, Spiegelman D, Rimm EB, Colditz
GA, Stampfer MJ, Willett WC. A prospective study of physical activity and prostate cancer in male health professionals.
Cancer Res. 1998;58(22):5117–22. https://pubmed.ncbi.nlm.nih.
gov/9823321/.
275. Giovannucci EL, Liu Y, Leitzmann MF, Stampfer MJ, Willett
WC. A prospective study of physical activity and incident and
fatal prostate cancer. Arch Intern Med. 2005;165(9):1005–10.
https://doi.org/10.1001/archinte.165.9.1005.
276. Hamer J, Warner E.Lifestyle modications for patients with breast
cancer to improve prognosis and optimize overall health. CMAJ.
2017;189(7):E268–74. https://doi.org/10.1503/cmaj.160464.
277. Lahart IM, Metsios GS, Nevill AM, Carmichael AR. Physical
activity, risk of death and recurrence in breast cancer survivors:
a systematic review and meta-analysis of epidemiological studies. Acta Oncol. 2015;54(5):635–54. https://doi.org/10.3109/028
4186x.2014.998275.
Role ofLifestyle Modication andDiet inthePrevention ofCancer
https://t.me/medicina_free
165
278. Spei ME, Samoli E, Bravi F, La Vecchia C, Bamia C, Benetou
V.Physical activity in breast cancer survivors: a systematic review
and meta-analysis on overall and breast cancer survival. Breast.
2019;44:144–52. https://doi.org/10.1016/j.breast.2019.02.001.
Соседние файлы в папке Библиотека им академика М.И. Перельмана